These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10820005)

  • 21. Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human activated protein C (APC). Sodium ion in the APC crystal structure is coordinated to four carbonyl groups from two separate loops.
    Schmidt AE; Padmanabhan K; Underwood MC; Bode W; Mather T; Bajaj SP
    J Biol Chem; 2002 Aug; 277(32):28987-95. PubMed ID: 12029084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for chemical inhibition of human blood coagulation factor Xa.
    Kamata K; Kawamoto H; Honma T; Iwama T; Kim SH
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6630-5. PubMed ID: 9618463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
    Rezaie AR; Yang L; Manithody C
    Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites.
    Dunwiddie CT; Neeper MP; Nutt EM; Waxman L; Smith DE; Hofmann KJ; Lumma PK; Garsky VM; Vlasuk GP
    Biochemistry; 1992 Dec; 31(48):12126-31. PubMed ID: 1457408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redesigning the monovalent cation specificity of an enzyme.
    Prasad S; Wright KJ; Banerjee Roy D; Bush LA; Cantwell AM; Di Cera E
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13785-90. PubMed ID: 14612565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.
    Wei A; Alexander RS; Duke J; Ross H; Rosenfeld SA; Chang CH
    J Mol Biol; 1998; 283(1):147-54. PubMed ID: 9761680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths.
    Wagenvoord R; Al Dieri R; van Dedem G; Béguin S; Hemker HC
    Thromb Res; 2008; 122(2):237-45. PubMed ID: 18045667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.
    Maiwald A; Hammami M; Wagner S; Heine A; Klebe G; Steinmetzer T
    J Enzyme Inhib Med Chem; 2016; 31(sup1):89-97. PubMed ID: 27168215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
    Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity.
    Reyda S; Sohn C; Klebe G; Rall K; Ullmann D; Jakubke HD; Stubbs MT
    J Mol Biol; 2003 Jan; 325(5):963-77. PubMed ID: 12527302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
    Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase.
    Vagin O; Munson K; Lambrecht N; Karlish SJ; Sachs G
    Biochemistry; 2001 Jun; 40(25):7480-90. PubMed ID: 11412101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the active site caging of serine proteases: thrombin and factor Xa.
    Thuring JW; Li H; Porter NA
    Biochemistry; 2002 Feb; 41(6):2002-13. PubMed ID: 11827547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition.
    Brandstetter H; Kühne A; Bode W; Huber R; von der Saal W; Wirthensohn K; Engh RA
    J Biol Chem; 1996 Nov; 271(47):29988-92. PubMed ID: 8939944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR
    Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of divalent and monovalent cations on some active site properties of human factor Xa.
    Manly DT; Featherstone GL; Jenzano JW; Roberts HR; Lundblad RL
    Thromb Res; 1988 Feb; 49(3):343-51. PubMed ID: 3163182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities.
    Águila S; Izaguirre G; Martínez-Martínez I; Vicente V; Olson ST; Corral J
    J Biol Chem; 2017 Oct; 292(40):16513-16520. PubMed ID: 28743742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.